Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling

M. Somlyay; E. Durinikova; J. Besnard; O. Barbeau; J. Le Coz; M. Senekowitsch; B. Ergüner; K. Hackner; L. Dzurillova; E. Petru; J. Lafleur; J. Singer; T. Füreder; R. Paveley; J. Joseph; F. Aswad; T. Winkler-Penz; R. Sehlke; C. Boudesco; G. Vladimer

doi:10.1016/S0959-8049(22)00919-4

Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling

M. Somlyay, E. Durinikova, J. Besnard, O. Barbeau, J. Le Coz, M. Senekowitsch, B. Ergüner, K. Hackner, L. Dzurillova, E. Petru, J. Lafleur, J. Singer, T. Füreder, R. Paveley, J. Joseph, F. Aswad, T. Winkler-Penz, R. Sehlke, C. Boudesco, G. Vladimer

Research output: Journal article (peer-reviewed) › Conference contribution to journal

Original language	English
Pages (from-to)	S44-S45
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)00919-4
Publication status	Published - Oct 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/S0959-8049(22)00919-4

Cite this

Somlyay, M., Durinikova, E., Besnard, J., Barbeau, O., Le Coz, J., Senekowitsch, M., Ergüner, B., Hackner, K., Dzurillova, L., Petru, E., Lafleur, J., Singer, J., Füreder, T., Paveley, R., Joseph, J., Aswad, F., Winkler-Penz, T., Sehlke, R., Boudesco, C., & Vladimer, G. (2022). Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling. European Journal of Cancer, 174, S44-S45. https://doi.org/10.1016/S0959-8049(22)00919-4

@article{9896946615cc4da3a48f0e045b563cea,

title = "Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling",

author = "M. Somlyay and E. Durinikova and J. Besnard and O. Barbeau and {Le Coz}, J. and M. Senekowitsch and B. Erg{\"u}ner and K. Hackner and L. Dzurillova and E. Petru and J. Lafleur and J. Singer and T. F{\"u}reder and R. Paveley and J. Joseph and F. Aswad and T. Winkler-Penz and R. Sehlke and C. Boudesco and G. Vladimer",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00919-4",

language = "English",

volume = "174",

pages = "S44--S45",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Somlyay, M, Durinikova, E, Besnard, J, Barbeau, O, Le Coz, J, Senekowitsch, M, Ergüner, B, Hackner, K, Dzurillova, L, Petru, E, Lafleur, J, Singer, J, Füreder, T, Paveley, R, Joseph, J, Aswad, F, Winkler-Penz, T, Sehlke, R, Boudesco, C & Vladimer, G 2022, 'Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling', European Journal of Cancer, vol. 174, pp. S44-S45. https://doi.org/10.1016/S0959-8049(22)00919-4

TY - JOUR

T1 - Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling

AU - Somlyay, M.

AU - Durinikova, E.

AU - Besnard, J.

AU - Barbeau, O.

AU - Le Coz, J.

AU - Senekowitsch, M.

AU - Ergüner, B.

AU - Hackner, K.

AU - Dzurillova, L.

AU - Petru, E.

AU - Lafleur, J.

AU - Singer, J.

AU - Füreder, T.

AU - Paveley, R.

AU - Joseph, J.

AU - Aswad, F.

AU - Winkler-Penz, T.

AU - Sehlke, R.

AU - Boudesco, C.

AU - Vladimer, G.

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85140465390&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(22)00919-4

DO - 10.1016/S0959-8049(22)00919-4

M3 - Conference contribution to journal

AN - SCOPUS:85140465390

SN - 0959-8049

VL - 174

SP - S44-S45

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this